Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults with Type 2 Diabetes

Trial Identifier: D6470C00005
Sponsor: AstraZeneca
PAREXEL International
NCTID:: NCT04556760
Start Date: November 2020
Primary Completion Date: June 2021
Study Completion Date: June 2021
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
DE Berlin, DE, 14050
DE Mainz, DE, 55116
DE Mannheim, DE, 68167
DE Neuss, DE, 41460